mFast‐SeqS‐based aneuploidy score in circulating cell‐free DNA is a prognostic biomarker in prostate cancer

Multiple prognostic biomarkers, including circulating tumour cell (CTC) counts, exist in metastatic castration‐resistant prostate cancer (mCRPC) patients, but none of them have been implemented into daily clinical care. The modified fast aneuploidy screening test‐sequencing system (mFast‐SeqS), whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Isebia, Khrystany T., Mostert, Bianca, Deger, Teoman, Kraan, Jaco, de Weerd, Vanja, Oomen‐de Hoop, Esther, Hamberg, Paul, Haberkorn, Brigitte C. M., Helgason, Helgi H., de Wit, Ronald, Mathijssen, Ron H. J., Lolkema, Martijn P., Wilting, Saskia M., van Riet, Job, Martens, John W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483599/
https://www.ncbi.nlm.nih.gov/pubmed/37178439
http://dx.doi.org/10.1002/1878-0261.13449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483599/
https://www.ncbi.nlm.nih.gov/pubmed/37178439
http://dx.doi.org/10.1002/1878-0261.13449

Ejemplares similares